All units actively do a good job of heatstroke prevention and cooling in high temperature season
Release time:
2020-08-17
All units actively do a good job in heatstroke prevention and cooling in high temperature season
News from our newspaper In order to effectively do a good job in heatstroke prevention and cooling in high temperature weather, all units under the peak have taken active actions and taken various measures to do a good job in heatstroke prevention and cooling to ensure the safe production of enterprises.
In order to ensure the normal construction of the West Phase II construction project, the construction unit reasonably arranges the production and life of workers in high temperature weather, and also requires the places of workers engaged in high temperature, heavy physical labor and open-air work to be equipped with heatstroke prevention and cooling items, and appropriately adjust the work and rest time, properly arrange rest, and ensure health and safety. A tea pavilion was also set up beside the middle passage of the construction site, with boiling buckets and a bucket full of chrysanthemum herbal tea for workers to drink during rest.
8# On the morning of August 6 , the security team of Jianfeng International Trading Company conducted heatstroke prevention and cooling inspections on Jinhua South Railway Station warehouse, Xiaohuang Village warehouse, shoe pond warehouse and all tenants in the park. The safety team checked the equipment of heatstroke prevention drugs and drinks in all warehouses and tenants. Refrigerators, exhaust fans, air ducts and other equipment are in place, and tenants are required to arrange their working hours reasonably to avoid over-time and single-person operation. At the same time, for the problems found in the inspection, the inspection team proposed rectification on the spot, reminding everyone to pay attention to the summer high temperature heat prevention, cooling and other work, implement the responsibility to everyone in each post, strengthen the daily on-site inspection, and eliminate all kinds of potential safety hazards in summer.
8# On December 7, the cable company used the morning meeting platform to organize employees to carry out training on heatstroke prevention and cooling safety knowledge, which was given by chief engineer Hu Longgang. The teaching content mainly includes the concept of high temperature and the harm caused by high temperature, the concept of heatstroke and the causes and symptoms of heatstroke, effective methods to prevent heatstroke and how to give correct first aid after heatstroke. The training deepened the employees' understanding of high temperature and heatstroke, enhanced their self-protection awareness and self-help and mutual rescue ability, effectively reduced the occurrence of safety accidents, and promoted the safety production of enterprises. (Song Shijie Xu Qin Huang Yuan)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page